World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
28493
World Ranking
13623
National Ranking
6922

Guido Dalbagni publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Guido Dalbagni sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 429 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Guido Dalbagni D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Guido Dalbagni sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Guido Dalbagni is affiliated with Memorial Sloan Kettering Cancer Center in the United States and has an extensive research portfolio primarily focused on medicine, with a particular emphasis on surgery, urology, and oncology. Their work spans both clinical and molecular investigations, incorporating subfields such as molecular biology and pulmonary and respiratory medicine.

Their research covers key topics related to bladder and urothelial cancer treatments, urinary and genital oncology studies, and urological disorders and treatments. Additional focal points include cancer immunotherapy and biomarkers, epigenetics and DNA methylation, esophageal cancer research and treatment, and studies on multiple and secondary primary cancers.

Dalbagni has contributed significantly to the literature, with notable frequent publication venues including:

  • The Journal of Urology
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Urologic Oncology Seminars and Original Investigations
  • European Urology

Frequent collaborators in their research include Bernard H. Bochner, Eugene J. Pietzak, S. Machele Donat, Hikmat Al-Ahmadie, and Harry W. Herr, reflecting sustained partnerships in advancing urological and oncological research.

Among selected recent papers, the following stand out:

  • Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma, 2023, Journal of Clinical Oncology
  • Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort, 2021, European Urology
  • Goal-directed versus Standard Fluid Therapy to Decrease Ileus after Open Radical Cystectomy, 2020, Anesthesiology
  • The impact of fluid optimisation before induction of anaesthesia on hypotension after induction, 2020, Anaesthesia
  • The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers, 2021, Advances in Anatomic Pathology

Dalbagni's body of work demonstrates a multidisciplinary approach integrating clinical treatment strategies with underlying molecular and immunologic mechanisms, contributing to improving knowledge in bladder and urothelial cancer management and related oncologic specialties.

Best Publications

  • Epidemiology and risk factors of urothelial bladder cancer

    Maximilian Burger;James W.F. Catto;Guido Dalbagni;H. Barton Grossman

  • Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

    Ahmad Shabsigh;Ruslan Korets;Kinjal C. Vora;Christine M. Brooks

  • Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update

    M. Craig Hall;Sam S. Chang;Guido Dalbagni;Raj Som Pruthi

  • Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

    Harry W. Herr;Bernard H. Bochner;Guido Dalbagni;S. Machele Donat

  • Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression

    Alvaro S. Sarkis;Guido Dalbagni;Carlos Cordon-Cardo;Zuo-Feng Zhang

  • Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

    Bernard H. Bochner;Guido Dalbagni;Daniel D. Sjoberg;Jonathan Silberstein;Jonathan Silberstein

  • Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.

    Bernard H. Bochner;Guido Dalbagni;Michael W. Kattan;Paul Fearn

  • CYSTECTOMY FOR BLADDER CANCER: A CONTEMPORARY SERIES

    Guido Dalbagni;Elizabeth Genega;Mia Hashibe;Zuo-Feng Zhang

  • Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder Cancer

    Carlos Cordon-Cardo;David Wartinger;Daniel Petrylak;Guido Dalbagni

  • Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.

    Atreya Dash;Matthew D. Galsky;Andrew J. Vickers;Angel M. Serio

  • Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer

    Theresa M. Koppie;Angel M. Serio;Andrew J. Vickers;Kinjal Vora

  • Urinary diversion after radical cystectomy for bladder cancer: Options, patient selection, and outcomes

    Richard K. Lee;Hassan Abol-Enein;Walter Artibani;Bernard Bochner

  • Genetic alterations in bladder cancer

    G. Dalbagni;J. Presti;W.R. Fair;V. Reuter

  • Phase I Trial of Intravesical Gemcitabine in Bacillus Calmette-Guérin–Refractory Transitional-Cell Carcinoma of the Bladder

    Guido Dalbagni;Paul Russo;Joel Sheinfeld;Madhu Mazumdar

  • Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.

    Eugene J. Pietzak;Aditya Bagrodia;Eugene K. Cha;Esther N. Drill

  • Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center Experience

    S. Machele Donat;Ahmad Shabsigh;Caroline Savage;Angel M. Cronin

  • p53 Mutations in human bladder cancer : genotypic versus phenotypic patterns

    Carlos Cordon-Cardo;Guido Dalbagni;Guillermo T. Saez;Maria R. Oliva

  • A Role for Neoadjuvant Gemcitabine Plus Cisplatin in Muscle-Invasive Urothelial Carcinoma of the Bladder: A Retrospective Experience

    Atreya Dash;Atreya Dash;Joseph A. Pettus;Joseph A. Pettus;Harry W. Herr;Harry W. Herr;Bernard H. Bochner;Bernard H. Bochner

  • Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?

    Theresa M. Koppie;Andrew J. Vickers;Kinjal Vora;Guido Dalbagni

  • Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

    H.W Herr;B.H Bochner;G Dalbagni;S.M Donat

Frequent Co-Authors

Bernard H. Bochner
Bernard H. Bochner Memorial Sloan Kettering Cancer Center
Harry W. Herr
Harry W. Herr Memorial Sloan Kettering Cancer Center
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
Jonathan E. Rosenberg
Jonathan E. Rosenberg Memorial Sloan Kettering Cancer Center
Hikmat Al-Ahmadie
Hikmat Al-Ahmadie Memorial Sloan Kettering Cancer Center
David B. Solit
David B. Solit Memorial Sloan Kettering Cancer Center
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center
Paul Russo
Paul Russo Memorial Sloan Kettering Cancer Center
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always have to start with medical school. There are several related online degrees and career pathways worth considering, many of which offer flexible and affordable learning options.

For those interested in administrative roles, affordable medical billing and coding programs are a practical choice. These courses prepare you for vital behind-the-scenes work in healthcare and can often be completed quickly.

Nursing remains a popular path, with multiple degree options available. If your goal is a direct-entry route, researching what is the cheapest online college for nursing? can help you find programs that fit your budget. Advanced roles, such as nurse practitioner, are accessible through affordable np programs that blend clinical training with online coursework.

For those aiming for leadership, research, or academic careers, there are opportunities to earn an online phd nursing. These programs allow nurses to reach the highest levels of expertise without sacrificing their professional or personal commitments.

Best Scientists Citing Guido Dalbagni

Trending Scientists